Literature DB >> 26740607

International variation in adherence to referral guidelines for suspected cancer: a secondary analysis of survey data.

Brian D Nicholson1, David Mant1, Richard D Neal2, Nigel Hart3, Willie Hamilton4, Bethany Shinkins1, Greg Rubin5, Peter W Rose1.   

Abstract

BACKGROUND: Variation in cancer survival persists between comparable nations and appears to be due, in part, to primary care practitioners (PCPs) having different thresholds for acting definitively in response to cancer-related symptoms. AIM: To explore whether cancer guidelines, and adherence to them, differ between jurisdictions and impacts on PCPs' propensity to take definitive action on cancer-related symptoms. DESIGN AND
SETTING: A secondary analysis of survey data from six countries (10 jurisdictions) participating in the International Cancer Benchmarking Partnership.
METHOD: PCPs' responses to five clinical vignettes presenting symptoms and signs of lung (n = 2), colorectal (n = 2), and ovarian cancer (n = 1) were compared with investigation and referral recommendations in cancer guidelines.
RESULTS: Nine jurisdictions had guidelines covering the two colorectal vignettes. For the lung vignettes, although eight jurisdictions had guidelines for the first, the second was covered by a Swedish guideline alone. Only the UK and Denmark had an ovarian cancer guideline. Survey responses of 2795 PCPs (crude response rate: 12%) were analysed. Guideline adherence ranged from 20-82%. UK adherence was lower than other jurisdictions for the lung vignette covered by the guidance (47% versus 58%; P <0.01) but similar (45% versus 46%) or higher (67% versus 38%; P <0.01) for the two colorectal vignettes. PCPs took definitive action least often when a guideline recommended a non-definitive action or made no recommendation. UK PCPs adhered to recommendations for definitive action less than their counterparts (P <0.01). There wasno association between jurisdictional guideline adherence and 1-year survival.
CONCLUSION: Cancer guideline content is variable between similarly developed nations and poor guideline adherence does not explain differential survival. Guidelines that fail to cover high-risk presentations or that recommend non-definitive action may reduce definitive diagnostic action. © British Journal of General Practice 2016.

Entities:  

Keywords:  diagnosis; early detection of cancer; neoplasms; practice guideline; primary health care; survival

Mesh:

Year:  2016        PMID: 26740607      PMCID: PMC4723209          DOI: 10.3399/bjgp16X683449

Source DB:  PubMed          Journal:  Br J Gen Pract        ISSN: 0960-1643            Impact factor:   5.386


  23 in total

1.  Margaret McCartney: Have we given guidelines too much power?

Authors:  Margaret McCartney
Journal:  BMJ       Date:  2014-10-06

2.  Referral of suspected colorectal cancer: have guidelines made a difference?

Authors:  Moyez Jiwa; William Hamilton
Journal:  Br J Gen Pract       Date:  2004-08       Impact factor: 5.386

3.  Referral letters to colorectal surgeons: the impact of peer-mediated feedback.

Authors:  Moyez Jiwa; Stephen Walters; Nigel Mathers
Journal:  Br J Gen Pract       Date:  2004-02       Impact factor: 5.386

Review 4.  Is increased time to diagnosis and treatment in symptomatic cancer associated with poorer outcomes? Systematic review.

Authors:  R D Neal; P Tharmanathan; B France; N U Din; S Cotton; J Fallon-Ferguson; W Hamilton; A Hendry; M Hendry; R Lewis; U Macleod; E D Mitchell; M Pickett; T Rai; K Shaw; N Stuart; M L Tørring; C Wilkinson; B Williams; N Williams; J Emery
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

5.  Preliminary results of a feasibility study of the use of information technology for identification of suspected colorectal cancer in primary care: the CREDIBLE study.

Authors:  E Kidney; L Berkman; A Macherianakis; D Morton; G Dowswell; W Hamilton; R Ryan; H Awbery; S Greenfield; T Marshall
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

6.  Explaining variation in cancer survival between 11 jurisdictions in the International Cancer Benchmarking Partnership: a primary care vignette survey.

Authors:  Peter W Rose; Greg Rubin; Rafael Perera-Salazar; Sigrun Saur Almberg; Andriana Barisic; Martin Dawes; Eva Grunfeld; Nigel Hart; Richard D Neal; Marie Pirotta; Jeffrey Sisler; Gerald Konrad; Berit Skjødeberg Toftegaard; Hans Thulesius; Peter Vedsted; Jane Young; Willie Hamilton
Journal:  BMJ Open       Date:  2015-05-27       Impact factor: 2.692

7.  How might healthcare systems influence speed of cancer diagnosis: a narrative review.

Authors:  Sally Brown; Michele Castelli; David J Hunter; Jonathan Erskine; Peter Vedsted; Catherine Foot; Greg Rubin
Journal:  Soc Sci Med       Date:  2014-06-24       Impact factor: 4.634

Review 8.  Understanding missed opportunities for more timely diagnosis of cancer in symptomatic patients after presentation.

Authors:  G Lyratzopoulos; P Vedsted; H Singh
Journal:  Br J Cancer       Date:  2015-03-31       Impact factor: 7.640

9.  Development of a survey instrument to investigate the primary care factors related to differences in cancer diagnosis between international jurisdictions.

Authors:  Peter W Rose; Willie Hamilton; Kate Aldersey; Andriana Barisic; Martin Dawes; Catherine Foot; Eva Grunfeld; Nigel Hart; Richard D Neal; Marie Pirotta; Jeffrey Sisler; Hans Thulesius; Peter Vedsted; Jane Young; Greg Rubin
Journal:  BMC Fam Pract       Date:  2014-06-17       Impact factor: 2.497

Review 10.  A review of clinical practice guidelines found that they were often based on evidence of uncertain relevance to primary care patients.

Authors:  Nicholas Steel; Asmaa Abdelhamid; Tim Stokes; Helen Edwards; Robert Fleetcroft; Amanda Howe; Nadeem Qureshi
Journal:  J Clin Epidemiol       Date:  2014-09-06       Impact factor: 6.437

View more
  16 in total

1.  Responsibility for follow-up during the diagnostic process in primary care: a secondary analysis of International Cancer Benchmarking Partnership data.

Authors:  Brian D Nicholson; Clare R Goyder; Clare R Bankhead; Berit S Toftegaard; Peter W Rose; Hans Thulesius; Peter Vedsted; Rafael Perera
Journal:  Br J Gen Pract       Date:  2018-04-23       Impact factor: 5.386

2.  Urgent cancer referrals: how well are they working and can they be improved?

Authors:  Richard D Neal; Lesley Smith
Journal:  Br J Gen Pract       Date:  2021-08-26       Impact factor: 6.302

Review 3.  Reimagining the diagnostic pathway for gastrointestinal cancer.

Authors:  Greg Rubin; Fiona Walter; Jon Emery; Niek de Wit
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2018-02-07       Impact factor: 46.802

4.  Direct access cancer testing in primary care: a systematic review of use and clinical outcomes.

Authors:  Claire Friedemann Smith; Alice C Tompson; Nicholas Jones; Josh Brewin; Elizabeth A Spencer; Clare R Bankhead; Fd Richard Hobbs; Brian D Nicholson
Journal:  Br J Gen Pract       Date:  2018-08-13       Impact factor: 5.386

5.  How the probability of presentation to a primary care clinician correlates with cancer survival rates: a European survey using vignettes.

Authors:  Michael Harris; Peter Frey; Magdalena Esteva; Svjetlana Gašparović Babić; Mercè Marzo-Castillejo; Davorina Petek; Marija Petek Ster; Hans Thulesius
Journal:  Scand J Prim Health Care       Date:  2017-03-06       Impact factor: 2.581

6.  Cancer suspicion in general practice, urgent referral, and time to diagnosis: a population-based GP survey nested within a feasibility study using information technology to flag-up patients with symptoms of colorectal cancer.

Authors:  Elaine Kidney; Sheila Greenfield; Lindy Berkman; George Dowswell; William Hamilton; Sally Wood; Tom Marshall
Journal:  BJGP Open       Date:  2017-10-04

7.  Development of an intervention to expedite cancer diagnosis through primary care: a protocol.

Authors:  Marian Andrei Stanciu; Rebecca-Jane Law; Sadia Nafees; Maggie Hendry; Seow Tien Yeo; Julia Hiscock; Ruth Lewis; Rhiannon T Edwards; Nefyn H Williams; Katherine Brain; Paul Brocklehurst; Andrew Carson-Stevens; Sunil Dolwani; Jon Emery; William Hamilton; Zoe Hoare; Georgios Lyratzopoulos; Greg Rubin; Stephanie Smits; Peter Vedsted; Fiona Walter; Clare Wilkinson; Richard D Neal
Journal:  BJGP Open       Date:  2018-09-05

8.  General practitioners' awareness of the recommendations for faecal immunochemical tests (FITs) for suspected lower gastrointestinal cancers: a national survey.

Authors:  Christian Von Wagner; Sandro Tiziano Stoffel; Madeline Freeman; Helga E Laszlo; Brian D Nicholson; Jessica Sheringham; Dorothy Szinay; Yasemin Hirst
Journal:  BMJ Open       Date:  2019-04-11       Impact factor: 2.692

9.  Patients' initial steps to cancer diagnosis in Denmark, England and Sweden: what can a qualitative, cross-country comparison of narrative interviews tell us about potentially modifiable factors?

Authors:  John MacArtney; Marlene Malmström; Trine Overgaard Nielsen; Julie Evans; Britt-Marie Bernhardson; Senada Hajdarevic; Alison Chapple; Lars E Eriksson; Louise Locock; Birgit Rasmussen; Peter Vedsted; Carol Tishelman; Rikke Sand Andersen; Sue Ziebland
Journal:  BMJ Open       Date:  2017-11-19       Impact factor: 2.692

10.  Diagnostic routes and time intervals for patients with colorectal cancer in 10 international jurisdictions; findings from a cross-sectional study from the International Cancer Benchmarking Partnership (ICBP).

Authors:  Usha Menon; Peter Vedsted; David Weller; Alina Zalounina Falborg; Henry Jensen; Andriana Barisic; Anne Kari Knudsen; Rebecca J Bergin; David H Brewster; Victoria Cairnduff; Anna T Gavin; Eva Grunfeld; Elizabeth Harland; Mats Lambe; Rebecca-Jane Law; Yulan Lin; Martin Malmberg; Donna Turner; Richard D Neal; Victoria White; Samantha Harrison; Irene Reguilon
Journal:  BMJ Open       Date:  2018-11-27       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.